These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28470177)

  • 1. Heart failure: No effect of ularitide in heart failure outcomes.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2017 Jun; 14(6):316. PubMed ID: 28470177
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamic and clinical effects of ularitide in decompensated heart failure.
    Mitrovic V; Seferovic PM; Simeunovic D; Ristic AD; Miric M; Moiseyev VS; Kobalava Z; Nitsche K; Forssmann WG; Lüss H; Meyer M
    Eur Heart J; 2006 Dec; 27(23):2823-32. PubMed ID: 17074775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure.
    Packer M; Holcomb R; Abraham WT; Anker S; Dickstein K; Filippatos G; Krum H; Maggioni AP; McMurray JJV; Mebazaa A; O'Connor C; Peacock F; Ponikowski P; Ruschitzka F; van Veldhuisen DJ; Holzmeister J;
    Eur J Heart Fail; 2017 May; 19(5):673-681. PubMed ID: 27862700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure.
    Packer M; O'Connor C; McMurray JJV; Wittes J; Abraham WT; Anker SD; Dickstein K; Filippatos G; Holcomb R; Krum H; Maggioni AP; Mebazaa A; Peacock WF; Petrie MC; Ponikowski P; Ruschitzka F; van Veldhuisen DJ; Kowarski LS; Schactman M; Holzmeister J;
    N Engl J Med; 2017 May; 376(20):1956-1964. PubMed ID: 28402745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized double-blind clinical studies of ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta-analysis.
    Mitrovic V; Forssmann WG; Schnitker J; Felix SB
    ESC Heart Fail; 2018 Dec; 5(6):1023-1034. PubMed ID: 30246939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic use of the natriuretic peptide ularitide in acute renal failure.
    Meyer M; Pfarr E; Schirmer G; Uberbacher HJ; Schöpe K; Böhm E; Flüge T; Mentz P; Scigalla P; Forssmann WG
    Ren Fail; 1999 Jan; 21(1):85-100. PubMed ID: 10048120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of ularitide in patients with decompensated heart failure.
    Lüss H; Mitrovic V; Seferovic PM; Simeunovic D; Ristić AD; Moiseyev VS; Forssmann WG; Hamdy AM; Meyer M
    Am Heart J; 2008 Jun; 155(6):1012.e1-8. PubMed ID: 18513512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation.
    Brenner P; Meyer M; Reichenspurner H; Meiser B; Müller R; Mentz P; Schulz-Knappe P; Uberbacher HJ; Kreuzer E; Uberführ P
    Eur J Med Res; 1995 Dec; 1(3):137-43. PubMed ID: 9389675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.
    Elsner D; Muders F; Müntze A; Kromer EP; Forssmann WG; Riegger GA
    Am Heart J; 1995 Apr; 129(4):766-73. PubMed ID: 7900630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ularitide: a natriuretic peptide candidate for the treatment of acutely decompensated heart failure.
    Emani S; Meyer M; Palm D; Holzmeister J; Haas GJ
    Future Cardiol; 2015 Sep; 11(5):531-46. PubMed ID: 26278236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with vessel dilator and kaliuretic hormone in persons with congestive heart failure.
    Patel H; Dietz JR; Owen A; San Miguel G; McCormick MT; Schocken DD; Vesely DL
    Exp Biol Med (Maywood); 2004 Jun; 229(6):521-7. PubMed ID: 15169971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies.
    Anker SD; Ponikowski P; Mitrovic V; Peacock WF; Filippatos G
    Eur Heart J; 2015 Mar; 36(12):715-23. PubMed ID: 25670819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of low dose intravenous 99-126 atrial natriuretic factor infusion in patients with chronic renal failure.
    Woolf AS; Mansell MA; Hoffbrand BI; Cohen SL; Moult PJ
    Postgrad Med J; 1989 Jun; 65(764):362-6. PubMed ID: 2532741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of alpha-human atrial natriuretic polypeptide on patients undergoing open-heart surgery.
    Ohki S; Ishikawa S; Ohtaki A; Takahashi T; Koyano T; Otani Y; Murakami J; Mohara J; Isa Y; Kunimoto F; Morishita Y
    J Cardiovasc Surg (Torino); 1999 Dec; 40(6):781-5. PubMed ID: 10776705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
    Nishi K; Sato Y; Miyamoto T; Toma M; Taniguchi R; Fukuhara R; Saijo S; Fujiwara H; Takatsu Y
    J Cardiol; 2012 May; 59(3):366-73. PubMed ID: 22365946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure.
    Oya H; Nagaya N; Furuichi S; Nishikimi T; Ueno K; Nakanishi N; Yamagishi M; Kangawa K; Miyatake K
    Am J Cardiol; 2000 Jul; 86(1):94-8. PubMed ID: 10867102
    [No Abstract]   [Full Text] [Related]  

  • 17. [Natriuretic peptides in the therapy of acute decompensated heart failure].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1738-43. PubMed ID: 21877307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience of carperitide (synthetic human-atrial natriuretic peptide) after cardiovascular surgery].
    Taniyasu N; Koh E; Hiramatsu T
    Kyobu Geka; 1996 May; 49(5):359-63. PubMed ID: 8992036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure.
    Fifer MA; Molina CR; Quiroz AC; Giles TD; Herrmann HC; De Scheerder IR; Clement DL; Kubo S; Cody RJ; Cohn JN
    Am J Cardiol; 1990 Jan; 65(3):211-6. PubMed ID: 2136969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.